For example, CRISPRa and CRISPRi screening of CCR7 expression revealed that Basic Leucine Zipper ATF-Like Transcription Factor 3 (BATF3) overexpression boosts specific TMEM traits, enhancing HER2+ CAR-T efficacy against breast cancer [54]. This evidence concerns the gene BATF3 and breast carcinoma.